02186 LUYE PHARMA
- 2.570
- -0.050-1.91%
LUYE PHARMA News
LUYE PHARMA: Completion of the Issue of U.S.$180,000,000 6.25 per cent. Convertible Bonds due 2028
LUYE PHARMA: PROPOSED ISSUE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028
LUYE PHARMA: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
LUYE PHARMA: PLACING OF NEW SHARES UNDER GENERAL MANDATE
LUYE PHARMA: PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - LISTING OF BOAN BIOTECH AND COMMENCEMENT OF DEALINGS IN THE H SHARES OF BOAN BIOTECH
LUYE PHARMA: PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - GLOBAL OFFERING
LUYE PHARMA: PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - PUBLICATION OF PROSPECTUS BY BOAN BIOTECH - EXPECTED SIZE OF THE GLOBAL OFFERING AND OFFER PRICE
LUYE PHARMA: PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - BASIS OF ASSURED ENTITLEMENT OF QUALIFYING SHAREHOLDERS IN THE PREFERENTIAL OFFERING
LUYE PHARMA: PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE POST HEARING INFORMATION PACK
LUYE PHARMA: UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH - RECORD DATE FOR ASSURED ENTITLEMENT AND CLOSURE OF REGISTER OF MEMBERS
LUYE PHARMA: ISSUE OF CONVERTIBLE BONDS
LUYE PHARMA: PROPOSED ISSUE OF CONVERTIBLE BONDS
LUYE PHARMA: ISSUE OF CONVERTIBLE BONDS
LUYE PHARMA: PROPOSED ISSUE OF CONVERTIBLE BONDS
LUYE PHARMA: UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH
LUYE PHARMA: ANNOUNCEMENT - (1) COMPLETION OF ISSUE OF NEW SHARES UNDER GENERAL MANDATE (2) COMPLETION OF SALE OF EXISTING SHARES BY CONTROLLING SHAREHOLDER AND (3) APPOINTMENT OF NON-EXECUTIVE DIRECTOR
LUYE PHARMA: ANNOUNCEMENT - (1) ISSUE OF NEW SHARES UNDER GENERAL MANDATE AND (2) SALE OF EXISTING SHARES BY CONTROLLING SHAREHOLDER
LUYE PHARMA: ANNOUNCEMENT - (1) PROPOSED ISSUE OF NEW SHARES UNDER GENERAL MANDATE AND (2) PROPOSED SALE OF EXISTING SHARES BY CONTROLLING SHAREHOLDER
LUYE PHARMA: CLOSURE OF REGISTER OF MEMBERS FOR SPECIAL GENERAL MEETING
LUYE PHARMA: COMPLETION OF THE ISSUE OF US$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Analysis
Price Target
No Data
